Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
22 hedge funds and large institutions have $4.81M invested in Celgene Corporation Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
4% less funds holding
Funds holding: 23 → 22 (-1)
12% less capital invested
Capital invested by funds: $5.45M → $4.81M (-$642K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
+$17.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.4K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$136 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$269K |
| 2 |
Millennium Management
New York
|
-$15.8K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$10.8K |
| 4 |
MSTVIM
Messner & Smith Theme Value Investment Management
San Diego,
California
|
-$10K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9K |
CELGZ Hedge Fund Activity: Q1 2015 in Review
22 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q1 2015, worth a combined $4.81M — down 12% from $5.45M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELGZ and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 2 added.
The largest buyer was Davenport & Co, adding an estimated $17.1K. The largest seller was Opaleye Management, cutting an estimated $269K.
- 22 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q1 2015, down from 23 in Q4 2014.
- Funds reported $4.81M of Celgene Corporation Contingent Value Rights stock for Q1 2015, down 12% quarter-over-quarter.
- 1 fund opened new Celgene Corporation Contingent Value Rights positions in Q1 2015 and 2 closed out, a net change of -1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q1 2015 was Davenport & Co, an estimated $17.1K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q1 2015 was Opaleye Management, an estimated $269K sold.
Based on aggregated 13F filings for Q1 2015.